Latest Shows & Articles

Subscriptions
  • Join our People's Pharmacy Page on Facebook
  • Follow JoeGraedon on Twitter
  • Follow Us
  • Free email newsletter

Print This Page

Diabetes Drug Linked to Bone Loss

  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Not Helpful ..... Very Helpful
Was this information helpful? Average rating: 5/5 (4 votes)
What do you think? Click the stars to vote!
If you have more to say, post a comment below!

Type 2 diabetes is one of the most serious chronic conditions of the 21st century. Diagnoses of new cases, especially in young people, continue to accelerate. Two medications that are frequently used in the treatment of type-2 diabetes are Avandia and Actos. These so-called glitazone compounds boost insulin sensitivity and decrease insulin resistance. This helps improve blood sugar control. But questions have been raised about the effect of glitazones on bone metabolism. A recent review in the journal Drug Safety concludes that "glitazone use is associated with accelerated bone loss and an increased risk of fracture in humans." 
[Drug Safety, July 1, 2009]
  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Not Helpful ..... Very Helpful
Was this information helpful? Average rating: 5/5 (4 votes)
What do you think? Click the stars to vote!
If you have more to say, post a comment below!

Leave a comment

Share your comments or questions with the People's Pharmacy online community. Not all comments will be posted. Advice from other visitors to this web site should not be considered a substitute for appropriate medical attention. Concerns about medications should be discussed with a health professional. Do not stop any medication without first checking with your physician.

Check this box to be notified by email when follow-up comments are posted.